Founder and Chief Scientific Officer
PhD | FMedSci
Jason has a long track record in defining hormone dependent cancer and the study of transcription factors in cancer. Jason has published in leading journals, including Nature, Cell, Nature Genetics and is on the editorial board for numerous journals. He trained in Australia, Dana-Farber Cancer Institute/Harvard Medical School, Boston and has been faculty at Cancer Research UK (CRUK), University of Cambridge since 2006, where he is currently a Director of Research. He is the recipient of the AACR Outstanding Investigator award (2013), the Louis-Jeantet Foundation Award (2014) and is a member of EMBO and a Fellow of the Academy of Medical Sciences. He was elected as a Komen Scholar in 2016.